glycine has been researched along with Autosomal Dominant Cerebellar Ataxia, Type II in 10 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To study parkinsonism, dementia, dystonia, and amyotrophy as subphenotypes of SCA2, and to explore the effect of CAG repeats at different loci and of mitochondrial polymorphism A10398G as modifiers of phenotype." | 1.46 | Neurological phenotypes in spinocerebellar ataxia type 2: Role of mitochondrial polymorphism A10398G and other risk factors. ( Augustin, MC; Barsottini, O; Jardim, LB; Locks-Coelho, LD; Monte, TL; Pedroso, JL; Pereira, FS; Reckziegel, EDR; Santos, ASP; Saraiva-Pereira, ML; Vargas, FR, 2017) |
| "Several of these syndromes are associated with an encephalopathy that characteristically shows episodes of rapid neurological deterioration and the development of acute cerebral lesions." | 1.36 | Localized cerebral energy failure in DNA polymerase gamma-associated encephalopathy syndromes. ( Bindoff, LA; Engelsen, BE; Ersland, L; Moen, G; Mørk, SJ; Neckelmann, G; Tzoulis, C; Viscomi, C; Zeviani, M, 2010) |
| "Spinocerebellar ataxia type 14 (SCA14) is a rare form of autosomal dominant cerebellar ataxias caused by mutations in the protein kinase Cgamma gene (PRKCG)." | 1.33 | A Japanese case of SCA14 with the Gly128Asp mutation. ( Ikeda, SI; Morita, H; Suzuki, K; Yoshida, K, 2006) |
| "We previously discovered spinocerebellar ataxia type 14 (SCA14) in a single Japanese family with an autosomal dominant neurodegenerative disorder characterized by cerebellar ataxia and intermittent axial myoclonus." | 1.32 | Spinocerebellar ataxia type 14 caused by a mutation in protein kinase C gamma. ( Bird, TD; Chen, DH; Kikuchi, S; Raskind, WH; Sasaki, H; Tashiro, K; Tsuji, S; Yabe, I; Yamashita, I, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (70.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Monte, TL | 1 |
| Pereira, FS | 1 |
| Reckziegel, EDR | 1 |
| Augustin, MC | 1 |
| Locks-Coelho, LD | 1 |
| Santos, ASP | 1 |
| Pedroso, JL | 1 |
| Barsottini, O | 1 |
| Vargas, FR | 1 |
| Saraiva-Pereira, ML | 1 |
| Jardim, LB | 1 |
| Safaei, S | 1 |
| Houshmand, M | 1 |
| Banoei, MM | 1 |
| Panahi, MS | 1 |
| Nafisi, S | 1 |
| Parivar, K | 1 |
| Rostami, M | 1 |
| Shariati, P | 1 |
| Tanabe, M | 1 |
| Nakano, T | 1 |
| Honda, M | 1 |
| Ono, H | 1 |
| Liu, J | 1 |
| Tang, TS | 1 |
| Tu, H | 1 |
| Nelson, O | 1 |
| Herndon, E | 1 |
| Huynh, DP | 1 |
| Pulst, SM | 1 |
| Bezprozvanny, I | 1 |
| Tzoulis, C | 1 |
| Neckelmann, G | 1 |
| Mørk, SJ | 1 |
| Engelsen, BE | 1 |
| Viscomi, C | 1 |
| Moen, G | 1 |
| Ersland, L | 1 |
| Zeviani, M | 1 |
| Bindoff, LA | 1 |
| Sailer, A | 1 |
| Scholz, SW | 1 |
| Gibbs, JR | 1 |
| Tucci, A | 1 |
| Johnson, JO | 1 |
| Wood, NW | 1 |
| Plagnol, V | 1 |
| Hummerich, H | 1 |
| Ding, J | 1 |
| Hernandez, D | 1 |
| Hardy, J | 1 |
| Federoff, HJ | 1 |
| Traynor, BJ | 1 |
| Singleton, AB | 1 |
| Houlden, H | 1 |
| Sultan, F | 1 |
| König, T | 1 |
| Möck, M | 1 |
| Thier, P | 1 |
| Alonso, I | 1 |
| Barros, J | 1 |
| Tuna, A | 1 |
| Coelho, J | 1 |
| Sequeiros, J | 1 |
| Silveira, I | 1 |
| Coutinho, P | 1 |
| Yabe, I | 1 |
| Sasaki, H | 1 |
| Chen, DH | 1 |
| Raskind, WH | 1 |
| Bird, TD | 1 |
| Yamashita, I | 1 |
| Tsuji, S | 1 |
| Kikuchi, S | 1 |
| Tashiro, K | 1 |
| Morita, H | 1 |
| Yoshida, K | 1 |
| Suzuki, K | 1 |
| Ikeda, SI | 1 |
10 other studies available for glycine and Autosomal Dominant Cerebellar Ataxia, Type II
| Article | Year |
|---|---|
Neurological phenotypes in spinocerebellar ataxia type 2: Role of mitochondrial polymorphism A10398G and other risk factors.
Topics: Adult; Aged; Alanine; Ataxin-2; Dementia; Dystonia; Female; Genetic Predisposition to Disease; Glyci | 2017 |
Mitochondrial tRNALeu/Lys and ATPase 6/8 gene variations in spinocerebellar ataxias.
Topics: Alanine; Amino Acid Substitution; Ataxin-3; Ataxin-7; Ataxins; Calcium Channels; DNA; DNA Primers; G | 2009 |
Glycine transporter blockade ameliorates motor ataxia in a mouse model of spinocerebellar atrophy.
Topics: Animals; Binding Sites; Cytarabine; Disease Models, Animal; Dose-Response Relationship, Drug; Glycin | 2009 |
Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 2.
Topics: Animals; Ataxins; Calcium; Calcium Channel Blockers; Calcium Signaling; Cell Death; Cells, Cultured; | 2009 |
Localized cerebral energy failure in DNA polymerase gamma-associated encephalopathy syndromes.
Topics: Arginine; Brain; Brain Diseases; Cerebellum; Cysteine; Diffuse Cerebral Sclerosis of Schilder; Diffu | 2010 |
Exome sequencing in an SCA14 family demonstrates its utility in diagnosing heterogeneous diseases.
Topics: Adolescent; Adult; Aged; Arginine; Exome; Genetic Testing; Glycine; Humans; Middle Aged; Mutation; P | 2012 |
Quantitative organization of neurotransmitters in the deep cerebellar nuclei of the Lurcher mutant.
Topics: Animals; Cell Count; Cerebellar Nuclei; gamma-Aminobutyric Acid; Glutamic Acid; Glycine; Immunohisto | 2002 |
Phenotypes of spinocerebellar ataxia type 6 and familial hemiplegic migraine caused by a unique CACNA1A missense mutation in patients from a large family.
Topics: Adolescent; Adult; Alanine; Child; Cysteine; Female; Genetic Linkage; Glycine; Hemiplegia; Humans; L | 2003 |
Spinocerebellar ataxia type 14 caused by a mutation in protein kinase C gamma.
Topics: Adult; Aged; Arginine; Base Sequence; Case-Control Studies; Glycine; Heterozygote; Humans; Male; Mid | 2003 |
A Japanese case of SCA14 with the Gly128Asp mutation.
Topics: Adult; Amino Acid Sequence; Amino Acid Substitution; Aspartic Acid; Base Sequence; Cerebellum; Femal | 2006 |